At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 164 enrolled
Drug / intervention
CorPath robotic-assisted PCIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
In Brief
A Phase 2 clinical trial evaluating CorPath robotic-assisted PCI for Coronary Artery Disease and 7 related conditions. Completed, enrolled 164 participants across 9 sites in 2 countries.
Detailed Summary
The objective of this study is to evaluate the safety and effectiveness of the clinical and technical performance of the CorPath® 200 System in the delivery and manipulation of coronary guidewires and stent/balloon systems for use in percutaneous coronary interventions (PCI).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Coronary Disease, Myocardial Ischemia, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases
CountriesColombia, United States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedJan 2011
Primary CompletionDec 2011
Study CompletionJan 2012
TodayJul 2026
First PostedJan 12, 2011
Enrollment StartJan 1, 2011
Primary CompletionDec 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.5 years ago
Interventions
CorPath robotic-assisted PCIdevice
CorPath 200® robotic-assisted percutaneous coronary intervention